
Matt Miksic
Stock Analyst at Barclays
(3.84)
# 1,950
Out of 5,189 analysts
827
Total ratings
53.6%
Success rate
3%
Average return
Main Sectors:
Stocks Rated by Matt Miksic
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ABT Abbott Laboratories | Initiated Coverage: Buy | $143 → $120 | $103.00 | +16.50% | 51 | Oct 7, 2026 | |
| AVR Anteris Technologies Global | Initiated Coverage: Hold | $18 → $10 | $4.99 | +100.40% | 7 | Oct 7, 2026 | |
| BAX Baxter International | Initiated Coverage: Sell | $27 → $20 | $25.39 | -21.23% | 42 | Oct 7, 2026 | |
| BDX Becton, Dickinson and Company | Initiated Coverage: Sell | $204 → $165 | $212.78 | -22.46% | 24 | Oct 7, 2026 | |
| BLCO Bausch + Lomb | Initiated Coverage: Buy | $20 → $24 | $19.38 | +23.84% | 19 | Oct 7, 2026 | |
| BSX Boston Scientific | Initiated Coverage: Hold | $89 → $48 | $41.98 | +14.34% | 51 | Oct 7, 2026 | |
| DXCM DexCom | Initiated Coverage: Buy | $64 → $115 | $79.32 | +44.98% | 23 | Oct 7, 2026 | |
| EW Edwards Lifesciences | Initiated Coverage: Buy | $110 | $101.85 | +8.00% | 59 | Oct 7, 2026 | |
| GEHC GE HealthCare Technologies | Initiated Coverage: Buy | $78 → $85 | $80.64 | +5.41% | 8 | Oct 7, 2026 | |
| HUMA Humacyte | Initiated Coverage: Hold | $1.5 → $0.5 | $0.4454 | +12.26% | 5 | Oct 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $651 → $485 | $399.05 | +21.54% | 20 | Oct 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $76 → $105 | $90.73 | +15.73% | 22 | Oct 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $198 → $150 | $133.17 | +12.64% | 21 | Oct 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $31 → $10 | $8.02 | +24.69% | 8 | Oct 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $394 → $375 | $310.00 | +20.97% | 49 | Oct 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $55 → $18 | $17.46 | +3.09% | 20 | Oct 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $94 → $100 | $101.10 | -1.09% | 41 | Oct 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $103 → $60 | $58.88 | +1.90% | 7 | Oct 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $120 → $95 | $99.94 | -4.94% | 69 | Oct 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $26 → $22 | $16.01 | +37.41% | 2 | Oct 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $255 | $270.47 | -5.72% | 93 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $12 → $13 | $6.58 | +97.57% | 7 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $123 | $66.89 | +83.88% | 49 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $21 → $19 | $12.42 | +52.98% | 26 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $27 → $24 | $6.68 | +259.28% | 16 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | CHFย 75.93 → CHFย 65.81 | CHFย 62.28 | +5.66% | 21 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 | $0.7716 | n/a | 15 | May 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $722 → $418 | $155.17 | n/a | 3 | May 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $16 → $13 | $0.001 | n/a | 2 | Mar 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $31 → $28 | $15.91 | n/a | 3 | Mar 2, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $74 → $67 | $8.29 | n/a | 5 | Mar 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $100 | $83.52 | n/a | 3 | Feb 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $79 → $87 | $13.25 | n/a | 25 | Nov 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $55 | $22.91 | n/a | 1 | Sep 30, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Sell | $9 | $3.05 | n/a | 1 | Dec 12, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $21 | $1.20 | n/a | 1 | Oct 31, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $37 | $29.83 | n/a | 1 | Nov 3, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $30 | $6.08 | n/a | 2 | Oct 10, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $33 → $36 | $46.56 | n/a | 2 | Jul 24, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $43 | $6.07 | n/a | 3 | Mar 14, 2013 |
Abbott Laboratories
Oct 7, 2026
Initiated Coverage: Buy
Price Target: $143 → $120
Current: $103.00
Upside: +16.50%
Anteris Technologies Global
Oct 7, 2026
Initiated Coverage: Hold
Price Target: $18 → $10
Current: $4.99
Upside: +100.40%
Baxter International
Oct 7, 2026
Initiated Coverage: Sell
Price Target: $27 → $20
Current: $25.39
Upside: -21.23%
Becton, Dickinson and Company
Oct 7, 2026
Initiated Coverage: Sell
Price Target: $204 → $165
Current: $212.78
Upside: -22.46%
Bausch + Lomb
Oct 7, 2026
Initiated Coverage: Buy
Price Target: $20 → $24
Current: $19.38
Upside: +23.84%
Boston Scientific
Oct 7, 2026
Initiated Coverage: Hold
Price Target: $89 → $48
Current: $41.98
Upside: +14.34%
DexCom
Oct 7, 2026
Initiated Coverage: Buy
Price Target: $64 → $115
Current: $79.32
Upside: +44.98%
Edwards Lifesciences
Oct 7, 2026
Initiated Coverage: Buy
Price Target: $110
Current: $101.85
Upside: +8.00%
GE HealthCare Technologies
Oct 7, 2026
Initiated Coverage: Buy
Price Target: $78 → $85
Current: $80.64
Upside: +5.41%
Humacyte
Oct 7, 2026
Initiated Coverage: Hold
Price Target: $1.5 → $0.5
Current: $0.4454
Upside: +12.26%
Oct 7, 2026
Initiated Coverage: Buy
Price Target: $651 → $485
Current: $399.05
Upside: +21.54%
Oct 7, 2026
Initiated Coverage: Buy
Price Target: $76 → $105
Current: $90.73
Upside: +15.73%
Oct 7, 2026
Initiated Coverage: Hold
Price Target: $198 → $150
Current: $133.17
Upside: +12.64%
Oct 7, 2026
Initiated Coverage: Hold
Price Target: $31 → $10
Current: $8.02
Upside: +24.69%
Oct 7, 2026
Initiated Coverage: Buy
Price Target: $394 → $375
Current: $310.00
Upside: +20.97%
Oct 7, 2026
Initiated Coverage: Hold
Price Target: $55 → $18
Current: $17.46
Upside: +3.09%
Oct 7, 2026
Initiated Coverage: Hold
Price Target: $94 → $100
Current: $101.10
Upside: -1.09%
Oct 6, 2026
Initiated Coverage: Hold
Price Target: $103 → $60
Current: $58.88
Upside: +1.90%
Oct 6, 2026
Initiated Coverage: Hold
Price Target: $120 → $95
Current: $99.94
Upside: -4.94%
Oct 6, 2026
Initiated Coverage: Hold
Price Target: $26 → $22
Current: $16.01
Upside: +37.41%
May 13, 2026
Reiterated: Hold
Price Target: $255
Current: $270.47
Upside: -5.72%
May 13, 2026
Rated: Buy
Price Target: $12 → $13
Current: $6.58
Upside: +97.57%
May 11, 2026
Reiterated: Buy
Price Target: $123
Current: $66.89
Upside: +83.88%
May 7, 2026
Reiterated: Buy
Price Target: $21 → $19
Current: $12.42
Upside: +52.98%
May 6, 2026
Reiterated: Buy
Price Target: $27 → $24
Current: $6.68
Upside: +259.28%
May 6, 2026
Reiterated: Hold
Price Target: CHFย 75.93 → CHFย 65.81
Current: CHFย 62.28
Upside: +5.66%
May 11, 2022
Reiterated: Buy
Price Target: $25
Current: $0.7716
Upside: n/a
May 4, 2022
Reiterated: Buy
Price Target: $722 → $418
Current: $155.17
Upside: n/a
Mar 4, 2022
Reiterated: Buy
Price Target: $16 → $13
Current: $0.001
Upside: n/a
Mar 2, 2022
Reiterated: Buy
Price Target: $31 → $28
Current: $15.91
Upside: n/a
Mar 1, 2022
Reiterated: Buy
Price Target: $74 → $67
Current: $8.29
Upside: n/a
Feb 16, 2022
Reiterated: Buy
Price Target: $100
Current: $83.52
Upside: n/a
Nov 3, 2021
Reiterated: Buy
Price Target: $79 → $87
Current: $13.25
Upside: n/a
Sep 30, 2021
Initiated Coverage: Buy
Price Target: $55
Current: $22.91
Upside: n/a
Dec 12, 2016
Initiated Coverage: Sell
Price Target: $9
Current: $3.05
Upside: n/a
Oct 31, 2016
Initiated Coverage: Buy
Price Target: $21
Current: $1.20
Upside: n/a
Nov 3, 2014
Reiterated: Hold
Price Target: $37
Current: $29.83
Upside: n/a
Oct 10, 2013
Downgraded: Hold
Price Target: $30
Current: $6.08
Upside: n/a
Jul 24, 2013
Rated: Hold
Price Target: $33 → $36
Current: $46.56
Upside: n/a
Mar 14, 2013
Reiterated: Hold
Price Target: $43
Current: $6.07
Upside: n/a